FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2282067939> ?p ?o ?g. }

• W2282067939 endingPage "113" @default.
• W2282067939 startingPage "106" @default.
• W2282067939 abstract "<b><i>Background:</i></b> Multiple sclerosis (MS) patients may be at an increased risk of comorbidities due to the debilitating and chronic nature of the disease. An increased understanding of comorbidities and disease course in MS may provide new insights and enhance MS management. We aimed at investigating the frequency of comorbidities and their associations with clinical disability and relapse in MS. <b><i>Methods:</i></b> A prospective cohort of 198 MS patients was followed during 2002-2005 and queried about specific doctor-diagnosed comorbidities. In Australia, the MS cohort was compared to the 2007 general population with regard to the prevalence of comorbidities. Multilevel mixed-effects linear regression was used to assess the difference in subsequent disability between those who reported comorbidities and those who did not. The association of comorbidities with the hazard of relapse was assessed using survival analysis. <b><i>Results:</i></b> The age-standardised prevalence of hypertension, dyslipidaemia, asthma, psoriasis, eczema and anaemia was significantly higher in the MS cohort compared to that in the general Australian population. The level of disability (Multiple Sclerosis Severity Score) in those who reported overweight/obesity (β: 0.76 (95% CI 0.04-1.48), p = 0.037), or dyslipidaemia (β: 1.05 (95% CI 0.07-2.02), p = 0.036) was significantly higher compared to those who did not report these comorbidities, even after adjustment for potential confounders. There were no significant associations between comorbidities and change in disability. For relapse analyses, rheumatoid arthritis and anaemia were associated with more than threefold (hazard ratio, HR 3.70 (95% CI 1.80-7.58), p < 0.001) and twofold (HR 2.04 (95% CI 1.11-3.74), p = 0.022) increased risk of subsequent relapse respectively. <b><i>Conclusions:</i></b> The prevalence of some comorbidities was higher in MS patients and associated with greater disability and relapse risk. Treatment of these comorbidities in patients with MS has the potential to improve disease course and help in the understanding of the prognosis and outcomes of MS." @default.
• W2282067939 created "2016-06-24" @default.
• W2282067939 creator A5013194494 @default.
• W2282067939 creator A5019766420 @default.
• W2282067939 creator A5042142014 @default.
• W2282067939 creator A5061692409 @default.
• W2282067939 creator A5067070663 @default.
• W2282067939 creator A5071467218 @default.
• W2282067939 creator A5073883447 @default.
• W2282067939 creator A5088112829 @default.
• W2282067939 date "2016-01-01" @default.
• W2282067939 modified "2023-10-18" @default.
• W2282067939 title "Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis" @default.
• W2282067939 cites W1547776311 @default.
• W2282067939 cites W1938188185 @default.
• W2282067939 cites W1964851953 @default.
• W2282067939 cites W1978097337 @default.
• W2282067939 cites W1983722147 @default.
• W2282067939 cites W1993822925 @default.
• W2282067939 cites W1996826715 @default.
• W2282067939 cites W2001927748 @default.
• W2282067939 cites W2010213472 @default.
• W2282067939 cites W2020022772 @default.
• W2282067939 cites W2035126508 @default.
• W2282067939 cites W2045680585 @default.
• W2282067939 cites W2057898127 @default.
• W2282067939 cites W2066851422 @default.
• W2282067939 cites W2072683582 @default.
• W2282067939 cites W2077713075 @default.
• W2282067939 cites W2086414808 @default.
• W2282067939 cites W2090193300 @default.
• W2282067939 cites W2094237226 @default.
• W2282067939 cites W2103136116 @default.
• W2282067939 cites W2105490558 @default.
• W2282067939 cites W2120088079 @default.
• W2282067939 cites W2122429701 @default.
• W2282067939 cites W2124296432 @default.
• W2282067939 cites W2125115221 @default.
• W2282067939 cites W2139344244 @default.
• W2282067939 cites W2145159920 @default.
• W2282067939 cites W2146793337 @default.
• W2282067939 cites W2161349124 @default.
• W2282067939 cites W2166733613 @default.
• W2282067939 cites W2168475359 @default.
• W2282067939 cites W2249586559 @default.
• W2282067939 doi "https://doi.org/10.1159/000442203" @default.
• W2282067939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26784322" @default.
• W2282067939 hasPublicationYear "2016" @default.
• W2282067939 type Work @default.
• W2282067939 sameAs 2282067939 @default.
• W2282067939 citedByCount "39" @default.
• W2282067939 countsByYear W22820679392016 @default.
• W2282067939 countsByYear W22820679392017 @default.
• W2282067939 countsByYear W22820679392018 @default.
• W2282067939 countsByYear W22820679392019 @default.
• W2282067939 countsByYear W22820679392020 @default.
• W2282067939 countsByYear W22820679392021 @default.
• W2282067939 countsByYear W22820679392022 @default.
• W2282067939 countsByYear W22820679392023 @default.
• W2282067939 crossrefType "journal-article" @default.
• W2282067939 hasAuthorship W2282067939A5013194494 @default.
• W2282067939 hasAuthorship W2282067939A5019766420 @default.
• W2282067939 hasAuthorship W2282067939A5042142014 @default.
• W2282067939 hasAuthorship W2282067939A5061692409 @default.
• W2282067939 hasAuthorship W2282067939A5067070663 @default.
• W2282067939 hasAuthorship W2282067939A5071467218 @default.
• W2282067939 hasAuthorship W2282067939A5073883447 @default.
• W2282067939 hasAuthorship W2282067939A5088112829 @default.
• W2282067939 hasConcept C118552586 @default.
• W2282067939 hasConcept C126322002 @default.
• W2282067939 hasConcept C188816634 @default.
• W2282067939 hasConcept C201903717 @default.
• W2282067939 hasConcept C207103383 @default.
• W2282067939 hasConcept C2779159551 @default.
• W2282067939 hasConcept C2780586474 @default.
• W2282067939 hasConcept C2780640218 @default.
• W2282067939 hasConcept C2908647359 @default.
• W2282067939 hasConcept C44249647 @default.
• W2282067939 hasConcept C511355011 @default.
• W2282067939 hasConcept C71924100 @default.
• W2282067939 hasConcept C72563966 @default.
• W2282067939 hasConcept C77350462 @default.
• W2282067939 hasConcept C99454951 @default.
• W2282067939 hasConceptScore W2282067939C118552586 @default.
• W2282067939 hasConceptScore W2282067939C126322002 @default.
• W2282067939 hasConceptScore W2282067939C188816634 @default.
• W2282067939 hasConceptScore W2282067939C201903717 @default.
• W2282067939 hasConceptScore W2282067939C207103383 @default.
• W2282067939 hasConceptScore W2282067939C2779159551 @default.
• W2282067939 hasConceptScore W2282067939C2780586474 @default.
• W2282067939 hasConceptScore W2282067939C2780640218 @default.
• W2282067939 hasConceptScore W2282067939C2908647359 @default.
• W2282067939 hasConceptScore W2282067939C44249647 @default.
• W2282067939 hasConceptScore W2282067939C511355011 @default.
• W2282067939 hasConceptScore W2282067939C71924100 @default.
• W2282067939 hasConceptScore W2282067939C72563966 @default.
• W2282067939 hasConceptScore W2282067939C77350462 @default.
• W2282067939 hasConceptScore W2282067939C99454951 @default.

• next